BioSmart Co.,Ltd. Stock

Equities

A038460

KR7038460002

Electronic Equipment & Parts

End-of-day quote Korea S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
5,390 KRW +4.66% Intraday chart for BioSmart Co.,Ltd. -2.71% +57.37%
Sales 2022 392B 283M Sales 2023 456B 329M Capitalization 69.89B 50.46M
Net income 2022 721M 521K Net income 2023 17.91B 12.93M EV / Sales 2022 0.32 x
Net Debt 2022 63.3B 45.7M Net Debt 2023 57.38B 41.43M EV / Sales 2023 0.28 x
P/E ratio 2022
88.6 x
P/E ratio 2023
6.15 x
Employees 162
Yield 2022 *
-
Yield 2023
-
Free-Float 69.71%
More Fundamentals * Assessed data
Dynamic Chart
An unknown buyer acquired a 15.6% stake in Taihan Copper Tech Co., Ltd. from BioSmart Co.,Ltd. for KRW 7 billion. CI
The Lamy Co., Ltd. completed the acquisition of 100% stake in Lamy Cosmetics Sales Co., Ltd. from BioSmart Co.,Ltd. and one unknown buyer. CI
Human N, Inc. agreed to acquire 100% stake in Lamy Cosmetics Sales Co., Ltd. from BioSmart Co.,Ltd. for KRW 19.2 billion. CI
Austin pharm.co.Ltd. announced that it has received KRW 9.9639456 billion in funding from BioSmart Co.,Ltd. CI
Austin pharm.co.Ltd. announced that it expects to receive KRW 9.9639456 billion in funding from BioSmart Co.,Ltd. CI
BioSmart Co.,Ltd.(KOSDAQ:A038460) dropped from S&P Global BMI Index CI
BioSmart Co.,Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors CI
Tranche Update on BioSmart Co.,Ltd.'s Equity Buyback Plan announced on February 25, 2020. CI
Tranche Update on BioSmart Co.,Ltd.'s Equity Buyback Plan announced on February 25, 2020. CI
Tranche Update on BioSmart Co.,Ltd.'s Equity Buyback Plan announced on February 25, 2020. CI
Tranche Update on BioSmart Co.,Ltd.'s Equity Buyback Plan announced on February 25, 2020. CI
Tranche Update on BioSmart Co.,Ltd.'s Equity Buyback Plan announced on February 25, 2020. CI
BioSmart Co.,Ltd.'s Equity Buyback announced on February 25, 2020, has expired with 888,603 shares, representing 4.45% for KRW 2,992.32 million. CI
BioSmart Co.,Ltd.(KOSDAQ:A038460) added to S&P Global BMI Index CI
BioSmart Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. CI
More news
1 day+4.66%
1 week-2.71%
1 month-2.71%
3 months+73.31%
6 months+56.23%
Current year+57.37%
More quotes
1 week
5 090.00
Extreme 5090
5 750.00
1 month
5 020.00
Extreme 5020
7 140.00
Current year
3 045.00
Extreme 3045
7 140.00
1 year
2 925.00
Extreme 2925
7 140.00
3 years
2 925.00
Extreme 2925
9 980.00
5 years
2 750.00
Extreme 2750
16 250.00
10 years
2 190.00
Extreme 2190
20 200.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 -
Chairman 54 -
Chief Tech/Sci/R&D Officer 64 -
Members of the board TitleAgeSince
Chairman 54 -
Chief Executive Officer 58 -
Director/Board Member 56 -
More insiders
Date Price Change Volume
24-05-31 5,390 +4.66% 1,512,782
24-05-30 5,150 -3.20% 817,137
24-05-29 5,320 -1.12% 2,769,402
24-05-28 5,380 -0.55% 1,065,359
24-05-27 5,410 -2.35% 1,330,638

End-of-day quote Korea S.E., May 30, 2024

More quotes
BioSmart Co., Ltd. is a Korea-based company mainly engaged in credit card business. The Company produces and issues domestic credit cards and electronic money systems under the brand name BS, and provides credit card issuing services, mailing systems, issuing equipment such as embossers and transcribers, and sending machines such as card sending machines and mail sending machines. Its card category includes magnetic stripe cards, integrated circuit (IC) cards, smart cards, combination cards, radio frequency (RF) cards, global systems for mobile communications (GSM) cards and others. The Company also involves in the manufacture of biological chips, cosmetics and health food through its affiliates.
More about the company
  1. Stock Market
  2. Equities
  3. A038460 Stock